The best indicator for Ameriprise Financial (AMP)
We backtested 20 indicators across daily, weekly and hourly charts on real Ameriprise Financial (AMP) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Donchian Midline
On the weekly chart, this is the strongest risk-adjusted edge we found for Ameriprise Financial (AMP) over ~20.8 years — trailing buy-and-hold by 1.3% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Donchian Midline ✓ | Weekly | 13.8% | 0.69 | -34.6% | 59.5% | 42 | -1.3% |
| 2 | SMA 50/200 Cross ✓ | Daily | 11.8% | 0.57 | -53.9% | 46.7% | 15 | -3.4% |
| 3 | EMA-10 Trend ✓ | Weekly | 9.8% | 0.53 | -54.8% | 53.2% | 94 | -5.4% |
| 4 | MACD ✓ | Weekly | 9.7% | 0.52 | -63.3% | 51.3% | 39 | -5.4% |
| 5 | RSI Trend (>50) ✓ | Weekly | 9.1% | 0.52 | -40.3% | 50.0% | 56 | -6.0% |
| 6 | ADX / DMI ✓ | Weekly | 8.2% | 0.52 | -42.0% | 55.6% | 36 | -7.0% |
| 7 | EMA 20/50 Cross ✓ | Daily | 9.3% | 0.51 | -40.4% | 42.6% | 47 | -5.8% |
| 8 | Donchian Breakout ✓ | Weekly | 7.6% | 0.48 | -30.9% | 47.1% | 17 | -7.5% |
| 9 | Donchian Breakout ✓ | Daily | 7.7% | 0.45 | -53.2% | 51.8% | 83 | -7.4% |
| 10 | EMA 50/200 Cross ✓ | Daily | 8.7% | 0.47 | -60.8% | 42.9% | 14 | -6.4% |
| 11 | Bollinger Breakout ✓ | Weekly | 4.8% | 0.38 | -44.4% | 55.6% | 18 | -10.3% |
| 12 | Bollinger Mean-Reversion ✓ | Daily | 6.4% | 0.37 | -51.1% | 76.1% | 88 | -8.7% |
| 13 | ADX / DMI | Daily | 5.0% | 0.36 | -38.7% | 52.1% | 140 | -10.1% |
| 14 | MACD ✓ | Daily | 5.7% | 0.34 | -70.7% | 43.3% | 210 | -9.4% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Ameriprise Financial (AMP), Donchian Midline on the weekly timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.